Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
Abstract Conventional maximum‐tolerated dose (MTD) chemotherapy relies on periodic, massive cancer cell ablation events followed by treatment‐free intermissions, stereotypically resulting in resistance, relapse, and mortality. Furthermore, MTD chemotherapy can promote metastatic dissemination via ac...
Main Authors: | Luana Schito, Sergio Rey, Ping Xu, Shan Man, William Cruz‐Muñoz, Robert S Kerbel |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2020-07-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201911416 |
Similar Items
-
Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01) -
Maintenance metronomic chemotherapy combined with conventional treatment for metastatic breast cancer patients
by: Sherif Elzawawy, et al.
Published: (2015-12-01) -
Impressive response to oral metronomic chemotherapy in ovarian cancer
by: Dinesh Shet, et al.
Published: (2022-12-01) -
Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy
by: Po-Hsiang Huang, et al.
Published: (2017-03-01) -
Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01)